CSF1R and cancer: Knowledge of the tissue-dependent metabolic effects of CSF1R inhibition is important in the development of immunomodulatory glucose-lowering drugs (e.g. liver-specific CSF1R inhibitors) or in the development of CSF1R inhibitors in cancer therapy [41].